These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 14623518)

  • 21. Aromatase inhibitors: assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression.
    Lønning PE; Geisler J
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):196-202. PubMed ID: 17996443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aromatase inhibitor development for treatment of breast cancer.
    Masamura S; Adlercreutz H; Harvey H; Lipton A; Demers LM; Santen RJ; Santner SJ
    Breast Cancer Res Treat; 1995; 33(1):19-26. PubMed ID: 7749129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma.
    Pasqualini JR; Cortes-Prieto J; Chetrite G; Talbi M; Ruiz A
    Int J Cancer; 1997 Mar; 70(6):639-43. PubMed ID: 9096642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.
    Geisler J; Haynes B; Ekse D; Dowsett M; Lønning PE
    J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):27-34. PubMed ID: 17350249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients.
    Bertelsen BE; Viste K; Helland T; Hagland M; Søiland H; Geisler J; Lende TH; Lønning PE; Sagen JV; Mellgren G; Almås B
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1368-1374. PubMed ID: 34958096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women.
    Dowsett M; Donaldson K; Tsuboi M; Wong J; Yates R
    Cancer Chemother Pharmacol; 2000; 46(1):35-9. PubMed ID: 10912575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer.
    Robarge JD; Desta Z; Nguyen AT; Li L; Hertz D; Rae JM; Hayes DF; Storniolo AM; Stearns V; Flockhart DA; Skaar TC; Henry NL
    Breast Cancer Res Treat; 2017 Feb; 161(3):453-461. PubMed ID: 27943008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer.
    Ingle JN; Buzdar AU; Schaid DJ; Goetz MP; Batzler A; Robson ME; Northfelt DW; Olson JE; Perez EA; Desta Z; Weintraub RA; Williard CV; Flockhart DA; Weinshilboum RM
    Cancer Res; 2010 Apr; 70(8):3278-86. PubMed ID: 20354183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women.
    Vermeulen A; Deslypere JP; Paridaens R; Leclercq G; Roy F; Heuson JC
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):515-25. PubMed ID: 3015631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial.
    Haddad TC; Suman VJ; Giridhar KV; Sideras K; Northfelt DW; Ernst BJ; O'Sullivan CC; Singh RJ; Desta Z; Peethambaram PP; Hobday TJ; Chumsri S; Leon-Ferre RA; Ruddy KJ; Yadav S; Taraba JL; Goodnature B; Goetz MP; Wang L; Ingle JN
    Clin Cancer Res; 2024 Aug; 30(15):3147-3156. PubMed ID: 38752717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.
    Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1984 Jul; 59(1):29-33. PubMed ID: 6725522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between aromatase inhibitors and sequential use.
    Lønning PE
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):275-82. PubMed ID: 14623521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane.
    Bertelsen BE; Almås B; Fjermeros K; Viste K; Geisler SB; Sauer T; Selsås K; Geisler J
    Breast Cancer Res Treat; 2024 Jul; 206(2):347-358. PubMed ID: 38649619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer.
    Demers LM; Lipton A; Harvey HA; Kambic KB; Grossberg H; Brady C; Santen RJ
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):687-91. PubMed ID: 8476785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local endocrine effects of aromatase inhibitors within the breast.
    Miller WR; Dixon JM
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):93-102. PubMed ID: 11850212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
    Lønning PE; Dowsett M; Powles TJ
    J Steroid Biochem; 1990 Mar; 35(3-4):355-66. PubMed ID: 2139151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.